ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01168219
Brief Title: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

First Submitted : July 22, 2010
First Submitted that Met QC Criteria : July 22, 2010
First Posted : July 23, 2010 (Estimate)

Results First Submitted : March 5, 2018
Results First Submitted that Met QC Criteria : March 5, 2018
Results First Posted : April 3, 2018

Last Update Submitted that Met QC Criteria : March 5, 2018
Last Update Posted : April 3, 2018